The VERSANT 440 Molecular System, the next generation bDNA instrument, combines clinically confident branched DNA (bDNA) chemistry with enhanced automation for an easy to use, robust and reliable, method of performing HIV and hepatitis viral load monitoring on a single platform.
Benefits
bDNA technology simplifies testing. Eliminates extraction, reduces potential of cross-contamination as compared to PCR methods.
Signal amplification methodology is designed to maximize accuracy while minimizing the impact of viral diversity.
Integrated platform processes up to 168 patient samples per run.
Minimal cost of operation through reduced consumables and hazardous waste.
Excellent assay precision and high reproducibility allow accurate detection of patient viral load changes with confidence.
Branched DNA technology is a clinically confident and reliable technology. On the VERSANT 440 Molecular System,-bDNA delivers accurate, reliable results while maximizing productivity and minimizing costs. A true workhorse for molecular HIV and Hepatitis testing.
